Genmab A/S ADR (GMAB)

$25.63 0.85 (3.23%)

11:34 EDT GMAB Stock Quote Delayed 30 Minutes

GMAB Stock Earnings: Genmab Misses EPS, Beats Revenue for Q2 2024

By InvestorPlace Earnings Aug 8, 2024

GMAB stock results show that Genmab missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.

7 Biotech Stocks to Buy on the Dip: June 2024

7 Stocks That Could Safely 10X by 2030

7 Biotech Stocks That Could Breathe New Life Into Your Portfolio

Volume:

Previous Close -

Market Cap -

PE Ratio -

EPS -

Volume (Avg. Vol.) 198,592

Day's Range $25.60 - $25.94

52-Week Range $24.53 - $37.97

Dividend & Yield N/A (N/A)

GMAB Stock Predictions, Articles, and Genmab A/S ADR News

GMAB Stock Earnings: Genmab Beats EPS, Beats Revenue for Q1 2024

By InvestorPlace Earnings May 2, 2024

GMAB stock results show that Genmab beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

7 Must-Buy Stocks That Are on Ridiculous Discount Now

By Josh Enomoto, InvestorPlace Contributor Nov 13, 2023

Given that this may be the year of artificial intelligence, it’s no surprise that while certain enterprises have hogged the spotlight, astute investors also enjoy…

7 Underappreciated Biotech Stocks to Pick Up on the Cheap

By Josh Enomoto, InvestorPlace Contributor Nov 9, 2023

Amid some rising questions for the economy, value-seeking investors may want to consider underappreciated biotech stocks. As a sector that, while not immune to broader…

3 Biotech Stocks You Better Be Buying on Each and Every Dip

By Tyrik Torres, InvestorPlace Contributor Jul 27, 2023

Biotech companies can bring about life-changing innovations. We've created a list to help you find the best biotech stocks out there.

3 Biotech Stocks That AI is Loving in July

By Gabriel Osorio-Mazzilli, InvestorPlace Contributor Jul 12, 2023

As AI becomes a more entrenched aspect of society, investors can lean on these AI recommended biotech stocks with predicted high potential.

3 Biotech Companies to Watch in 2023

By Muslim Farooque, InvestorPlace Contributor Jan 6, 2023

These biotech companies to watch are remarkably strong businesses that offer healthy upside potential as we head into a new year.

Our 7 Top Biotech Stock Picks for 2023

By Josh Enomoto, InvestorPlace Contributor Dec 9, 2022

Following the devastation of Covid-19, there’s greater interest toward medical innovations, thus bolstering biotech stock picks for 2023.

7 Top-Rated Stocks to Buy for a More Powerful Portfolio

By Louis Navellier, Editor, Growth Investor Jan 21, 2020

The market is hot, but that’s no reason to forgo quality when picking the top stocks to buy now. Here are seven that stand out from the rest.

10 Great Biotech Stocks to Buy in Q4

By Sarah Smith, Editor-in-Chief, InvestorPlace.com Oct 7, 2019

With FDA Breakthrough Therapy designations and robust drug pipelines, these biotech companies are all stocks to buy for 2020.

Genmab A/S ADR (GMAB)

GMAB Stock Earnings: Genmab Misses EPS, Beats Revenue for Q2 2024

7 Biotech Stocks to Buy on the Dip: June 2024

7 Biotech Stocks That Could Breathe New Life Into Your Portfolio

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Genmab A/S ADR (GMAB)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

GMAB Stock Predictions, Articles, and Genmab A/S ADR News

Subscriber Sign in